New uses for intravenous immune globulin
- PMID: 2052046
- DOI: 10.1056/NEJM199107113250209
New uses for intravenous immune globulin
Comment on
-
Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection.N Engl J Med. 1991 Jul 11;325(2):73-80. doi: 10.1056/NEJM199107113250201. N Engl J Med. 1991. PMID: 1675763 Clinical Trial.
-
Cost effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia.N Engl J Med. 1991 Jul 11;325(2):81-6. doi: 10.1056/NEJM199107113250202. N Engl J Med. 1991. PMID: 1904989 Clinical Trial.
Similar articles
-
Cost effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia.N Engl J Med. 1991 Jul 11;325(2):81-6. doi: 10.1056/NEJM199107113250202. N Engl J Med. 1991. PMID: 1904989 Clinical Trial.
-
Intravenous immune globulin therapy for antibody immunodeficiency.Clin Ther. 1984;7(1):69-72. Clin Ther. 1984. PMID: 6518465
-
A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group.N Engl J Med. 1994 Nov 3;331(18):1181-7. doi: 10.1056/NEJM199411033311802. N Engl J Med. 1994. PMID: 7935655 Clinical Trial.
-
NIH consensus conference. Intravenous immunoglobulin. Prevention and treatment of disease.JAMA. 1990 Dec 26;264(24):3189-93. JAMA. 1990. PMID: 2255028 Review. No abstract available.
-
[Therapy with immunoglobulins].Dtsch Med Wochenschr. 1986 Apr 4;111(14):550-6. doi: 10.1055/s-2008-1068489. Dtsch Med Wochenschr. 1986. PMID: 3514195 Review. German. No abstract available.
Cited by
-
Effects of immunoglobulin G and low-dose amphotericin B on Candida albicans infections in burned mice.Antimicrob Agents Chemother. 1992 Mar;36(3):643-6. doi: 10.1128/AAC.36.3.643. Antimicrob Agents Chemother. 1992. PMID: 1622177 Free PMC article.
-
Effective prophylaxis of influenza A virus pneumonia in mice by topical passive immunotherapy with polyvalent human immunoglobulins or F(ab')2 fragments.Clin Exp Immunol. 1998 Mar;111(3):583-7. doi: 10.1046/j.1365-2249.1998.00538.x. Clin Exp Immunol. 1998. PMID: 9528903 Free PMC article.
-
Human antibodies to bacterial superantigens and their ability to inhibit T-cell activation and lethality.Antimicrob Agents Chemother. 2001 Feb;45(2):460-3. doi: 10.1128/AAC.45.2.460-463.2001. Antimicrob Agents Chemother. 2001. PMID: 11158741 Free PMC article. Clinical Trial.
-
Respiratory diseases.Postgrad Med J. 1992 Mar;68(797):160-73. doi: 10.1136/pgmj.68.797.160. Postgrad Med J. 1992. PMID: 1589373 Free PMC article. Review. No abstract available.
-
Criteria for the appropriate drug utilisation of immunoglobulin.Pharmacoeconomics. 1996 May;9(5):417-29. doi: 10.2165/00019053-199609050-00005. Pharmacoeconomics. 1996. PMID: 10160254 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical